Balchem Corp cash flow to debt ratio of 112.78% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

Balchem Corp's free cash flow has increased 18.27% from $146.34M last year to $173.07M, signaling increasing performance

Balchem Corp's debt to equity ratio is 0.13, which means that the company's assets are healthy financed, signaling financial stability.

Balchem Corp's debt has decreased relative to shareholder equity from 0.18 last year to 0.13 today, signaling strengthened financials

Balchem Corp has a net debt to EBITDA ratio of 0.46x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Balchem Corp's interest coverage ratio of 25.29 indicates that earnings with good margin can cover interest payments on company debt

Balchem Corp's profit margin has increased (12.39%) in the last year from 13.47% to 15.14%, signaling increasing performance

Balchem Corp's short-term assets of $365.61M exceed its short-term liabilities of $176.38M

Balchem Corp's return on assets of 9.75% is higher than the 5.00% threshold, indicating efficient asset utilization

Balchem Corp's return on equity of 12.79%, is lower than 15.00%, indicating bad performance

Balchem Corp's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Balchem Corp had positive net income in 5 out of 5 years, indicating stable and consistent earnings

Balchem Corp has positive free cash flow, indicating the company generates cash after capital expenditures

Balchem Corp has a free cash flow yield of 3.04%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Balchem Corp's yearly earnings has increased 20.53% since last year from $128.47M to $154.84M, signaling increasing performance

Balchem Corp's yearly revenue has increased 8.75% since last year from $953.68M to $1.04B, signaling increasing performance

ROIC 11.50% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Balchem Corp's 3-year revenue CAGR of 3.25% is positive, indicating growing revenue over the past 3 years

Balchem Corp had revenue growth in 4 out of 5 years, indicating consistent revenue performance

Balchem Corp had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

Balchem Corp is overvalued relative to its fair value price of 84.58 based on Discounted Cash Flow model

Balchem Corp has an earnings yield of 2.88%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

Balchem Corp is overvalued relative to its fair value price of 51.37 based on EBITDA multiple model

Balchem Corp has an EV/EBITDA ratio of 22.84x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings

Balchem Corp is overvalued relative to its fair value price of 107.28 based on Earnings Fair Value model

Balchem Corp has a PEG-ratio over 1 which is considered overvalued

Balchem Corp has a price-to-book ratio of 4.39x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Balchem Corp has a price-to-sales ratio of 5.26x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue